The global holter ECG market is expected to grow from US$ 757.26 million in 2022 to US$ 1,215.76 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

The growth of the market is attributed to the cardiovascular diseases (CVDs). However, the lack of skilled professionals leading to inaccurate Holter ECG analysis is hindering the market growth.

An ECG Holter monitor is a wearable device which helps in tracking the proper functioning of the heart. This device is used to conduct test, especially on individuals susceptible to developing a cardiovascular disease. The individual is asked to wear the device for around two to three days, where the heart's activity is tracked down. The data obtained is then analyzed with the help of an analysis software, which helps the doctors to suggest an appropriate treatment to the patient.

North America is likely to dominate the Holter ECG market during the forecast period. The US held the largest share of the North American market in 2021 and is expected to continue this trend during the forecast period. Increasing adoption of technological advancement products in ECG and growing prevalence of atrial fibrillation are projected to accelerate the growth of the Holter ECG market. Moreover, the presence of large healthcare businesses and the growing usage of Holter ECG in hospitals and home care settings is propelling the market's expansion in this region.

The Holter ECG market is segmented on the basis of component, application, end user, indication, and channel, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The Holter ECG report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Holter ECG Market: Strategic Insights

Holter ECG Market

• 
  CAGR (2022 - 2028)

  8.2%
• Market Size 2022
  US$ 757.26 Million
• Market Size 2028
  US$ 1,215.76 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• DENSHI
• General Electric Co
• EB Neuro SPA
• Koninklijke Philips NV
• Viatom Technology Co., Ltd.
• Nihon Kohden Corp
• INNOMED MEDICAL ZRT
• OSI Systems, Inc.
• Hill Rom Holding Inc. (Baxter)

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Component

• Products
• Software & Solutions
• Services
• Accessories

Application

• Diagnostics and Monitoring

Indication

• Atrial Fibrillation

Channel

• 3 Channel ECG System
• 5
• 6 & 7 Channel ECG System
• 12 Channel ECG System
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Rising Prevalence of Cardiovascular Diseases (CVDs)

In the last decade, the world witnessed notable developments in Holter ECG monitors, aiding physicians and patients with new approaches to manage diseases such as atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation. Holter ECG monitors are gaining significant traction as these are simpler and quicker tools used for detecting arrhythmias. Holter monitoring is noninvasive, safer, and effective for patient monitoring. Therefore, a 24-hour Holter monitor is widely adopted in Europe and intended for the early detection of arrhythmias in patients suffering from a high clinical suspicion of atrial fibrillation (AF). For example, a 24-hour Holter monitor in a clinical study has revealed a 96.3% sensitivity and 96.8% specificity for the detection of AF. Most types of CVDs can be prevented through pre-monitoring and pre-diagnosis. Likewise, arrhythmias, i.e., abnormalities in the heart functioning, can be averted with early diagnosis. The demand for arrhythmia monitoring devices is increasing as these devices can help save patients at a high risk of cardiac arrest. This results in the adoption of new and innovative devices by the healthcare industry that help provide enhanced medical care and better healthcare facilities, which, in turn, is boosting demand for monitoring devices such as Holter ECG monitors. To avoid risks associated with CVDs, Holter ECGs are widely used by people likely to be exposed to factors that cause CVD. A Holter ECG monitor records the heart's activity (ECG) continuously for 24–48 hours, which is essential for safe diagnosis and therapy control. This is a major factor fueling its demand. Thus, the rising incidence of CVDs is increasing the demand for Holter ECG globally.

Component-Based Insights

Based on component, the global Holter ECGs market is segmented into products, software & solutions, services, and accessories. The products segment held the largest share of the market in 2021. However, the software & solutions segment is expected to register the highest CAGR in the market during the forecast period. Holter monitoring software has advanced remarkably in recent years. Most companies have useful analytical software that can be used to generate halter monitoring reports quickly and accurately. 

In addition, many halter companies offer advanced reporting capabilities through intelligent ECG algorithms. Market players are launching new products for market development. For instance, in Nov 2020, Abbott launched the new EnSite X EP System and received CE Mark and approval throughout Europe and Australia. The EnSite X System offered the option to navigate the cardiac anatomy two different ways on one platform and expanded the company’s electrophysiology portfolio. Cardiac mapping systems allowed electrophysiologists to create a heart map and helped them get a clear picture of the electrical signals that control cardiac rhythms.

In Sept 2021, Johnson & Johnson (Biosense Webster) announced successful post-approval procedures with the first-ever HELIOSTAR Balloon Ablation Catheter, a radiofrequency balloon ablation catheter at sites across Europe. In Europe, the catheter was used in the cardiac electrophysiological mapping of the atria and for cardiac ablation.

Application-Based Insights

Based on application, the global Holter ECGs market is bifurcated into diagnostics and monitoring. The diagnostics segment held a larger share of the market in 2021. However, the monitoring segment is anticipated to register a higher CAGR in the market from 2022 to 2028. A Holter monitor provides a complete picture of heart activity necessary for the diagnosis of cardiac conditions. The monitor records the heart’s behavior continuously. An electrocardiogram is a painless, noninvasive way to help diagnose many common heart problems in people of all ages. However, it may not provide as comprehensive of results as is received from the Holter monitor. As the Holter ECG displays the electrical activity of the heart, which is useful for determining irregular heart rate and heart rhythm abnormalities. It can also be used to diagnose coronary heart disease or the occurrence of a heart attack. Finally, a routine ECG can help to monitor the effects of prescribed cardiac medication.

The device is simple to operate, and it does not require additional medical training from the user. They are increasing the patient's comfort by telemonitoring at home and mobility of the device, which allows patients to function normally in their daily routines. Furthermore, the increasing prevalence of conditions such as cardiovascular diseases is also likely to boost segment growth. In addition, age-related conditions such as heart disease are also expected to boost the growth of the home settings segment by 2028. 

End User Insights

Based on end user, the global Holter ECG market is categorized as hospitals & clinics, ambulatory surgical centers, home settings, and others. In 2021, the hospitals segment held a larger share of the market. However, the home settings segment is expected to register a higher CAGR in the market during forecast period. Conventional diagnostics procedure for sepsis takes a few days. Thus, conventional diagnostics method is slowly adopted than automated diagnostics. Also, companies focus on developing automated diagnostics based on advanced technologies, such as molecular diagnostics for detecting sepsis.

Product launches and collaborations are highly adopted strategies by the global Holter ECG market players to expand their global footprints and product portfolios. The players also focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. They aim to flourish their market shares with the development of innovative products. A few of the recent key market developments are listed below: 

In January 2022, Royal Philips introduced the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.

Holter ECG Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Holter ECG – Market Segmentation

The global Holter ECG market is segmented on the basis of component, application, end user, indication, and channel. In terms of component, the global Holter ECG market is segmented into products, software & solutions, services, and accessories. Based on application, the market is bifurcated into diagnostics and monitoring. In terms of end user, the market is categorized into hospitals & clinics, ambulatory surgical centers, home settings, and others. Based on indication, the global Holter ECG market is segregated into atrial fibrilation (AF), cardiac arrest, patients with pacemakers, and others. In terms of channel, the market is segmented into 3 Channel ECG System, 5,6 & 7 Channel ECG System, 12 Channel ECG System, and others.

Company profile

• BPL Medical Technologies
• FUKUDA DENSHI     
• General Electric Co            
• Koninklijke Philips NV        
• Nihon Kohden Corp           
• OSI Systems, Inc.    
• SCHILLER Americas Inc.     
• EB Neuro S.P.A       
• Hill Rom Holding Inc. (Baxter)       
• Viatom Technology Co., Ltd.